{"transactions":[{"id":724990,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-06-29T20:19:33.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 25, 2027 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":95000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001718112-26-000002","document":"form4-06292026_080629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000171811226000002/form4-06292026_080629.xml","form_type":"4"}},{"id":1119015,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-06-09T20:21:03.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":82000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 5, 2026 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":82000,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":82000},"source":{"system":"sec-edgar","filing":"0001415889-25-016255","document":"form4-06092025_080648.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016255/form4-06092025_080648.xml","form_type":"4"}},{"id":1478183,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2024-06-17T20:17:58.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":82000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2025 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":82000,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":82000},"source":{"system":"sec-edgar","filing":"0001415889-24-017184","document":"form4-06172024_080655.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017184/form4-06172024_080655.xml","form_type":"4"}},{"id":1491055,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2024-06-05T20:06:42.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":false,"shares":58369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":23023,"derivative":{"exercise_price":10.38,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":58369},"source":{"system":"sec-edgar","filing":"0001415889-24-015544","document":"form4-06052024_080636.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015544/form4-06052024_080636.xml","form_type":"4"}},{"id":1491054,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2024-06-05T20:06:42.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":false,"shares":6289,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As of June 13, 2022, the option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":9.0165,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":6289},"source":{"system":"sec-edgar","filing":"0001415889-24-015544","document":"form4-06052024_080636.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015544/form4-06052024_080636.xml","form_type":"4"}},{"id":1491053,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Common Stock","published_at":"2024-06-05T20:06:42.000Z","date":"2024-06-03","kind":"sale","planned":false,"acquired":false,"shares":58369,"price":33.6495,"value":1964087.6655,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.27 to $34.08 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"shares","element":"transactionShares","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.27 to $34.08 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.27 to $34.08 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":13383,"source":{"system":"sec-edgar","filing":"0001415889-24-015544","document":"form4-06052024_080636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015544/form4-06052024_080636.xml","form_type":"4"}},{"id":1491052,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Common Stock","published_at":"2024-06-05T20:06:42.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":true,"shares":58369,"price":10.38,"value":605870.22,"ownership":{"direct":true},"balance_after":71752,"source":{"system":"sec-edgar","filing":"0001415889-24-015544","document":"form4-06052024_080636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015544/form4-06052024_080636.xml","form_type":"4"}},{"id":1491051,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Common Stock","published_at":"2024-06-05T20:06:42.000Z","date":"2024-06-03","kind":"exercise","planned":false,"acquired":true,"shares":6289,"price":9.0165,"value":56704.7685,"ownership":{"direct":true},"balance_after":13383,"source":{"system":"sec-edgar","filing":"0001415889-24-015544","document":"form4-06052024_080636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015544/form4-06052024_080636.xml","form_type":"4"}},{"id":1496030,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2024-06-03T20:06:26.000Z","date":"2024-05-30","kind":"exercise","planned":false,"acquired":false,"shares":2608,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":81392,"derivative":{"exercise_price":10.38,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":2608},"source":{"system":"sec-edgar","filing":"0001415889-24-015148","document":"form4-06032024_080622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015148/form4-06032024_080622.xml","form_type":"4"}},{"id":1496029,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2024-06-03T20:06:26.000Z","date":"2024-05-30","kind":"exercise","planned":false,"acquired":false,"shares":2043,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"As of June 13, 2022, the option is fully vested."}],"balance_after":6289,"derivative":{"exercise_price":9.0165,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":2043},"source":{"system":"sec-edgar","filing":"0001415889-24-015148","document":"form4-06032024_080622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015148/form4-06032024_080622.xml","form_type":"4"}},{"id":1496028,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2024-06-03T20:06:26.000Z","date":"2024-05-30","kind":"exercise","planned":false,"acquired":false,"shares":29068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"As of June 19, 2023, the option is fully vested."}],"balance_after":12732,"derivative":{"exercise_price":2.78,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":29068},"source":{"system":"sec-edgar","filing":"0001415889-24-015148","document":"form4-06032024_080622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015148/form4-06032024_080622.xml","form_type":"4"}},{"id":1496027,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Common Stock","published_at":"2024-06-03T20:06:26.000Z","date":"2024-05-30","kind":"sale","planned":false,"acquired":false,"shares":38719,"price":34.07,"value":1319156.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.850 to $34.445 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.850 to $34.445 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.850 to $34.445 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":7094,"source":{"system":"sec-edgar","filing":"0001415889-24-015148","document":"form4-06032024_080622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015148/form4-06032024_080622.xml","form_type":"4"}},{"id":1496026,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Common Stock","published_at":"2024-06-03T20:06:26.000Z","date":"2024-05-30","kind":"exercise","planned":false,"acquired":true,"shares":2608,"price":10.38,"value":27071.04,"ownership":{"direct":true},"balance_after":45813,"source":{"system":"sec-edgar","filing":"0001415889-24-015148","document":"form4-06032024_080622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015148/form4-06032024_080622.xml","form_type":"4"}},{"id":1496025,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Common Stock","published_at":"2024-06-03T20:06:26.000Z","date":"2024-05-30","kind":"exercise","planned":false,"acquired":true,"shares":2043,"price":9.0165,"value":18420.7095,"ownership":{"direct":true},"balance_after":43205,"source":{"system":"sec-edgar","filing":"0001415889-24-015148","document":"form4-06032024_080622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015148/form4-06032024_080622.xml","form_type":"4"}},{"id":1496024,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Common Stock","published_at":"2024-06-03T20:06:26.000Z","date":"2024-05-30","kind":"exercise","planned":false,"acquired":true,"shares":29068,"price":2.78,"value":80809.04,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 847 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan."}],"balance_after":41162,"source":{"system":"sec-edgar","filing":"0001415889-24-015148","document":"form4-06032024_080622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924015148/form4-06032024_080622.xml","form_type":"4"}},{"id":1850850,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2023-06-20T20:16:40.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 15, 2024 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":80000,"derivative":{"exercise_price":36.87,"exercise_date":"2024-06-15","expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001415889-23-010044","document":"form4-06202023_080633.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588923010044/form4-06202023_080633.xml","form_type":"4"}},{"id":2229182,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP OF REGULATORY AFFAIRS"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2022-06-17T20:16:19.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 16, 2023 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":77000,"derivative":{"exercise_price":22.48,"exercise_date":"2023-06-16","expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":77000},"source":{"system":"sec-edgar","filing":"0001415889-22-006728","document":"form4-06172022_010602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588922006728/form4-06172022_010602.xml","form_type":"4"}},{"id":2478274,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Affairs"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2021-12-10T21:02:38.000Z","date":"2021-12-08","kind":"exercise","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25 % vested on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":41800,"derivative":{"exercise_price":2.78,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001179110-21-010818","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911021010818/edgar.xml","form_type":"4"}},{"id":2478273,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Affairs"}}],"security":"Common Stock","published_at":"2021-12-10T21:02:38.000Z","date":"2021-12-08","kind":"sale","acquired":false,"shares":600,"price":40,"value":24000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of the shares of Common Stock were made pursuant to a plan intended to comply with Rule 10b5-1 of the Exchange Act, previously entered into on August 13, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of the shares of Common Stock were made pursuant to a plan intended to comply with Rule 10b5-1 of the Exchange Act, previously entered into on August 13, 2021."}],"balance_after":11247,"source":{"system":"sec-edgar","filing":"0001179110-21-010818","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911021010818/edgar.xml","form_type":"4"}},{"id":2478272,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Affairs"}}],"security":"Common Stock","published_at":"2021-12-10T21:02:38.000Z","date":"2021-12-08","kind":"exercise","acquired":true,"shares":600,"price":2.78,"value":1668.0,"ownership":{"direct":true},"balance_after":11847,"source":{"system":"sec-edgar","filing":"0001179110-21-010818","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911021010818/edgar.xml","form_type":"4"}},{"id":2527758,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Affairs"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2021-11-03T20:02:09.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25 % vested on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":42400,"derivative":{"exercise_price":2.78,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001179110-21-009815","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911021009815/edgar.xml","form_type":"4"}},{"id":2527757,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Affairs"}}],"security":"Common Stock","published_at":"2021-11-03T20:02:09.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":600,"price":41.71,"value":25026.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of the shares of Common Stock were made pursuant to a plan intended to comply with Rule 10b5-1 of the Exchange Act, previously entered into on August 13, 2021."},{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of the shares of Common Stock were made pursuant to a plan intended to comply with Rule 10b5-1 of the Exchange Act, previously entered into on August 13, 2021."}],"balance_after":11247,"source":{"system":"sec-edgar","filing":"0001179110-21-009815","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911021009815/edgar.xml","form_type":"4"}},{"id":2527756,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Affairs"}}],"security":"Common Stock","published_at":"2021-11-03T20:02:09.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":600,"price":2.78,"value":1668.0,"ownership":{"direct":true},"balance_after":11847,"source":{"system":"sec-edgar","filing":"0001179110-21-009815","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911021009815/edgar.xml","form_type":"4"}},{"id":2604676,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Affairs"}}],"security":"Incentive Stock Option","published_at":"2021-08-13T10:59:27.000Z","date":"2021-08-11","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This option was previously reported as covering 275,000 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% vested on June 13, 2019 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This option was previously reported as covering 275,000 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the Reverse Stock Split."}],"balance_after":8332,"derivative":{"exercise_price":9.0165,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-21-008164","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911021008164/edgar.xml","form_type":"4"}},{"id":2604675,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Affairs"}}],"security":"Common Stock","published_at":"2021-08-13T10:59:27.000Z","date":"2021-08-11","kind":"exercise","acquired":true,"shares":10000,"price":9.0165,"value":90165.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was previously reported as covering 275,000 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 247 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan.  On February 8, 2019, Celldex Therapeutics, Inc. effected a 1-for-15 reverse stock split of its common stock (the \"Reverse Stock Split\").  The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":11247,"source":{"system":"sec-edgar","filing":"0001179110-21-008164","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911021008164/edgar.xml","form_type":"4"}},{"id":2662453,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Affairs"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2021-06-21T20:29:24.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 17, 2022 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":62500,"derivative":{"exercise_price":28,"exercise_date":"2022-06-17","expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001179110-21-006910","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911021006910/edgar.xml","form_type":"4"}},{"id":3104885,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Affairs"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2020-06-19T12:07:02.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":84000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":84000,"derivative":{"exercise_price":10.38,"exercise_date":"2021-06-18","expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":84000},"source":{"system":"sec-edgar","filing":"0001179110-20-007597","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911020007597/edgar.xml","form_type":"4"}},{"id":3115621,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Affairs"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2020-06-10T11:55:27.000Z","date":"2020-06-09","kind":"purchase","acquired":true,"shares":1000,"price":3.005,"value":3005.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001179110-20-007167","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911020007167/edgar.xml","form_type":"4"}},{"id":3483522,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Affairs"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2019-06-20T20:28:49.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":43000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 19, 2020 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":43000,"derivative":{"exercise_price":2.78,"exercise_date":"2020-06-19","expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":43000},"source":{"system":"sec-edgar","filing":"0001179110-19-007977","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911019007977/edgar.xml","form_type":"4"}},{"id":3893275,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Affairs"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2018-06-15T11:57:21.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on June 13, 2019 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":275000,"derivative":{"exercise_price":0.6011,"exercise_date":"2019-06-13","expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001179110-18-008570","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911018008570/edgar.xml","form_type":"4"}},{"id":4196574,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":35032,"kind":"person","name":"Heath-Chiozzi Margo","position":1,"cik":"0001718112","reported_name":"Heath-Chiozzi Margo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP of Regulatory Affairs"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-10-03T21:27:22.000Z","date":"2017-10-03","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vest on October 3, 2018 and the remainder vests quarterly (in equal amounts) over the subsequent 12 quarters."}],"balance_after":75000,"derivative":{"exercise_price":3.01,"exercise_date":"2018-10-03","expiration_date":"2027-10-03","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000905718-17-000863","document":"chiozzi_fm4oct32017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000090571817000863/chiozzi_fm4oct32017.xml","form_type":"4"}}]}